Clik here to view.
Injunction against Natco refused: Public Interest Triumphs – Maybe
Image from hereSome very notable developments for those watching rare-disease litigation in India. On 24th March, in F Hoffman v. Natco, the Delhi High Court refused to grant an interim injunction...
View ArticleClik here to view.
CRI Guidelines 2025 is out for Public Consultations!
On 25th March 2025, the Patent Office officially released the Draft Guidelines for Examination of Computer-Related Inventions (CRI), 2025, for public consultations. Section 3(k) has been subject to...
View ArticleClik here to view.
Announcing the Winners of the 2024 Shamnad Basheer Essay Competition on...
Prof (Dr.) Shamnad Basheer 1976-2019; taken at NUJS, Kolkata circa 2009.We are very happy to announce the results of the 2024 Shamnad Basheer Essay Competition on Intellectual Property Law! The annual...
View ArticleClik here to view.
Part I- Applying Natural Intelligence (NI) to Artificial Intelligence (AI):...
In a fantastic 2 part post teasing apart how Large Language Models actually work, Shivam Kaushik gets down and dirty with the technical details of the algorithmic training process and explains why...
View ArticleClik here to view.
Part II- Applying Natural Intelligence (NI) to Artificial Intelligence (AI):...
Continuing from his earlier post, where he explained the technical workings of Large Language Models vis-a-vis where different copyright questions arise, in this post Shivam Kaushik argues that LLMS...
View ArticleClik here to view.
SpicyIP Weekly Review (March 24 – March 30)
Keep up with the ever-changing world of IP with SpicyIP’s Weekly Review! Wrapping up March with a busy week, here is a quick glance at the 11 posts- that include posts declaring the winners of the 2024...
View ArticleClik here to view.
Workshop on Access to Medicines, TRIPS, and Patents in the Developing World...
Third World Network (TWN) and the Inter-University Centre for IPR Studies, Cochin University of Science and Technology (CUSAT) are organising a five-day workshop on “Access to Medicines, TRIPS, and...
View ArticleClik here to view.
[Part I] India’s Hypocrisy over the TRIPs Waiver During the Pandemic
In a series of three hard-hitting posts, Prashant Reddy T exposes the alarming lack of transparency surrounding public funds spent on indigenously developed COVID-19 vaccines. He details his ordeal in...
View ArticleClik here to view.
[Part II] Public Money, Private Patents? Unravelling India’s Opacity over its...
Continuing the discussion on opacity behind the public money invested in development of COVID-19 vaccines, Prashant Reddy T, in Part II of his post, recounts his struggle with the government, including...
View ArticleClik here to view.
[Part III] Should Delhi High Court be Inviting Pharmaceutical Companies for...
After two hard-hitting posts (Part I and Part II) on transparency surrounding public money in COVID-19 vaccines, Prashant Reddy wraps up this three part saga with a curious incident. Here, he writes on...
View Article